A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
Titel:
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
Auteur:
Jonker, D.J. Rosen, L.S. Sawyer, M.B. de Braud, F. Wilding, G. Sweeney, C.J. Jayson, G.C. McArthur, G.A. Rustin, G. Goss, G. Kantor, J. Velasquez, L. Syed, S. Mokliatchouk, O. Feltquate, D.M. Kollia, G. Nuyten, D.S.A. Galbraith, S.